Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model

Fig. 2

A Representative images of wholemount retinal explants (n = 4/day) in culture at DEV 0 and DEV 5, immunolabeled with Brn3a (red) and RBPMS (green) at ×200 magnification (scale bar = 100 µm) treated daily with BNDF (200 ng/ml). B Quantification of Brn3a+ or RBPMS+ RGCs in control group (grey bar) and Brn3a+ or RBPMS+ RGCs in BDNF-treated group (black bar) at DEV 5 from wholemount retinal explants was expressed as percentage of DEV 0 (defined as 100%). Error bars are standard error of the mean. *P < 0.05, **P < 0.01

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094